Review




Structured Review

Proteintech septin 9
Septin 9, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 45 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/septin+9/SEPT9+Antibody/pm39503295-193-71-73
Average 92 stars, based on 45 article reviews
septin 9 - by Bioz Stars, 2026-11
92/100 stars

Images

Related Articles

Immunofluorescence:

Article Title: Borg5 restricts contractility and motility in epithelial MDCK cells
Article Snippet: .. The following primary antibodies were used for immunofluorescence (IF) and/or immunoblotting (IB): Cdc42EP1/Borg5 (Proteintech, 27904-1-AP, IB 1:500, IF 1:100); Myc tag (clone 9E10, home-made, IB and IF 1:500) or c-Myc tag (Proteintech #16286-1-AP, IF 1:250, IB 1:1000); Vinculin (Novus Biologicals, #NB120-11193, IF 1:100 or Proteintech 26520-1-AP, IF 1:600), ZO1 (clone R26.4C; , 1:50 IF); septin 2 (Proteintech #11397-1-AP, IF 1:300 and #60075-1-Ig, IB 1:1000; BiCell #0022, IF 1:100) Septin 9 (Proteintech # 10769-1-AP, IF 1:300), pThr18/pSer19-MLC2 (Cell Signaling #3674, IF 1:200), E-cadherin (clone RR1, deposited by Barry Gumbiner, University Virginia, with DSHB, Antibody Registry # AB_528114, IF 1:10), tubulin (clone YL1/2, Novus Biologicals, #NB600, IF 1:500), acetylated tubulin clone [6-11B-1] (Millipore Sigma #T6793 IF 1:200), HALO-tag (Promega #g928a, IB 1:500), β-actin [2D4H5] (Proteintech #66009-1-IG, IF: 1:500, IB 1:5000), Actinin α4 (ACTN4; Proteintech 19096-1-AP, IF 1:250), GAPDH [clone1E6D9] (Proteintech # 60004-1-Ig, IB 1:2000), 6xHis-tag [clone 1B7G5] (Proteintech # 66005-1-IG, IB 1:5000), Rac1 (BD Bioscience #610650, IB 1:500), and phospho-tyrosine ([clone PY20], Santa Cruz Biotechnology, sc508, IF 1:200). .. The following primary antibodies were used for immunofluorescence (IF) and/or immunoblotting (IB): Cdc42EP1/Borg5 (Proteintech, 27904-1-AP, IB 1:500, IF 1:100); Myc tag (clone 9E10, home-made, IB and IF 1:500) or c-Myc tag (Proteintech #16286-1-AP, IF 1:250, IB 1:1000); Vinculin (Novus Biologicals, #NB120-11193, IF 1:100 or Proteintech 26520-1-AP, IF 1:600), ZO1 (clone R26.4C; , 1:50 IF); septin 2 (Proteintech #11397-1-AP, IF 1:300 and #60075-1-Ig, IB 1:1000; BiCell #0022, IF 1:100) Septin 9 (Proteintech # 10769-1-AP, IF 1:300), pThr18/pSer19-MLC2 (Cell Signaling #3674, IF 1:200), E-cadherin (clone RR1, deposited by Barry Gumbiner, University Virginia, with DSHB, Antibody Registry # AB_528114, IF 1:10), tubulin (clone YL1/2, Novus Biologicals, #NB600, IF 1:500), acetylated tubulin clone [6-11B-1] (Millipore Sigma #T6793 IF 1:200), HALO-tag (Promega #g928a, IB 1:500), β-actin [2D4H5] (Proteintech #66009-1-IG, IF: 1:500, IB 1:5000), Actinin α4 (ACTN4; Proteintech 19096-1-AP, IF 1:250), GAPDH [clone1E6D9] (Proteintech # 60004-1-Ig, IB 1:2000), 6xHis-tag [clone 1B7G5] (Proteintech # 66005-1-IG, IB 1:5000), Rac1 (BD Bioscience #610650, IB 1:500), and phospho-tyrosine ([clone PY20], Santa Cruz Biotechnology, sc508, IF 1:200).

Article Title: Borg5 restricts contractility and motility in epithelial MDCK cells.
Article Snippet: The Borg (or Cdc42EP) family consists of septin-binding proteins that are known to promote septin-dependent stress fibers and actomyosin contractility.. We show here that epithelial Borg5 (also known as Cdc42EP1) instead limits contractility, cell–cell adhesion tension and motility, as is required for the acquisition of columnar, isotropic cell morphology in mature MDCK monolayers.. Borg5 depletion inhibited the development of the lateral F-actin cortex and stimulated microtubule-dependent leading-edge lamellae as well as radial stress fibers and, independently of the basal F-actin phenotype, caused anisotropy of apical surfaces within compacted monolayers.

Western Blot:

Article Title: Borg5 restricts contractility and motility in epithelial MDCK cells
Article Snippet: .. The following primary antibodies were used for immunofluorescence (IF) and/or immunoblotting (IB): Cdc42EP1/Borg5 (Proteintech, 27904-1-AP, IB 1:500, IF 1:100); Myc tag (clone 9E10, home-made, IB and IF 1:500) or c-Myc tag (Proteintech #16286-1-AP, IF 1:250, IB 1:1000); Vinculin (Novus Biologicals, #NB120-11193, IF 1:100 or Proteintech 26520-1-AP, IF 1:600), ZO1 (clone R26.4C; , 1:50 IF); septin 2 (Proteintech #11397-1-AP, IF 1:300 and #60075-1-Ig, IB 1:1000; BiCell #0022, IF 1:100) Septin 9 (Proteintech # 10769-1-AP, IF 1:300), pThr18/pSer19-MLC2 (Cell Signaling #3674, IF 1:200), E-cadherin (clone RR1, deposited by Barry Gumbiner, University Virginia, with DSHB, Antibody Registry # AB_528114, IF 1:10), tubulin (clone YL1/2, Novus Biologicals, #NB600, IF 1:500), acetylated tubulin clone [6-11B-1] (Millipore Sigma #T6793 IF 1:200), HALO-tag (Promega #g928a, IB 1:500), β-actin [2D4H5] (Proteintech #66009-1-IG, IF: 1:500, IB 1:5000), Actinin α4 (ACTN4; Proteintech 19096-1-AP, IF 1:250), GAPDH [clone1E6D9] (Proteintech # 60004-1-Ig, IB 1:2000), 6xHis-tag [clone 1B7G5] (Proteintech # 66005-1-IG, IB 1:5000), Rac1 (BD Bioscience #610650, IB 1:500), and phospho-tyrosine ([clone PY20], Santa Cruz Biotechnology, sc508, IF 1:200). .. The following primary antibodies were used for immunofluorescence (IF) and/or immunoblotting (IB): Cdc42EP1/Borg5 (Proteintech, 27904-1-AP, IB 1:500, IF 1:100); Myc tag (clone 9E10, home-made, IB and IF 1:500) or c-Myc tag (Proteintech #16286-1-AP, IF 1:250, IB 1:1000); Vinculin (Novus Biologicals, #NB120-11193, IF 1:100 or Proteintech 26520-1-AP, IF 1:600), ZO1 (clone R26.4C; , 1:50 IF); septin 2 (Proteintech #11397-1-AP, IF 1:300 and #60075-1-Ig, IB 1:1000; BiCell #0022, IF 1:100) Septin 9 (Proteintech # 10769-1-AP, IF 1:300), pThr18/pSer19-MLC2 (Cell Signaling #3674, IF 1:200), E-cadherin (clone RR1, deposited by Barry Gumbiner, University Virginia, with DSHB, Antibody Registry # AB_528114, IF 1:10), tubulin (clone YL1/2, Novus Biologicals, #NB600, IF 1:500), acetylated tubulin clone [6-11B-1] (Millipore Sigma #T6793 IF 1:200), HALO-tag (Promega #g928a, IB 1:500), β-actin [2D4H5] (Proteintech #66009-1-IG, IF: 1:500, IB 1:5000), Actinin α4 (ACTN4; Proteintech 19096-1-AP, IF 1:250), GAPDH [clone1E6D9] (Proteintech # 60004-1-Ig, IB 1:2000), 6xHis-tag [clone 1B7G5] (Proteintech # 66005-1-IG, IB 1:5000), Rac1 (BD Bioscience #610650, IB 1:500), and phospho-tyrosine ([clone PY20], Santa Cruz Biotechnology, sc508, IF 1:200).

Article Title: Borg5 restricts contractility and motility in epithelial MDCK cells.
Article Snippet: The Borg (or Cdc42EP) family consists of septin-binding proteins that are known to promote septin-dependent stress fibers and actomyosin contractility.. We show here that epithelial Borg5 (also known as Cdc42EP1) instead limits contractility, cell–cell adhesion tension and motility, as is required for the acquisition of columnar, isotropic cell morphology in mature MDCK monolayers.. Borg5 depletion inhibited the development of the lateral F-actin cortex and stimulated microtubule-dependent leading-edge lamellae as well as radial stress fibers and, independently of the basal F-actin phenotype, caused anisotropy of apical surfaces within compacted monolayers.

Plasmid Purification:

Article Title: Quantitative and Integrative Proteome Analysis of Peripheral Nerve Myelin Identifies Novel Myelin Proteins and Candidate Neuropathy Loci
Article Snippet: .. Antibodies were specific for PLP/DM20 ( Jung et al., 1996 ), plasmolipin ( Bosse et al., 2003 ), myelin and lymphocyte protein (MAL) ( Schaeren-Wiemers et al., 2004 ), PMP22 (ab15506, Abcam), CD9 (PharMingen), CD81 (PharMingen), CMTM5 (CKLF-like MARVEL-transmembrane domain-containing protein 5, also termed PETA-3; ab88964, Abcam; or M-13, Santa Cruz Biotechnology, yielding similar results), CD151 [455807, R&D Systems ( Cowin et al., 2006 )], septin 9 (SEPT9) [10769, Protein Tech Group and Nagata et al., (2004 ) (yielding similar results)], MAG (clone 513, Millipore Bioscience Research Reagents), 2′,3′-cyclic nucleotide phosphodiesterase (CNP; 11–5B, Sigma), COX4 (MS404, MitoSciences), and actin (Mab1501, Millipore Bioscience Research Reagents). . Immunoelectron microscopy. ..

Immuno-Electron Microscopy:

Article Title: Quantitative and Integrative Proteome Analysis of Peripheral Nerve Myelin Identifies Novel Myelin Proteins and Candidate Neuropathy Loci
Article Snippet: .. Antibodies were specific for PLP/DM20 ( Jung et al., 1996 ), plasmolipin ( Bosse et al., 2003 ), myelin and lymphocyte protein (MAL) ( Schaeren-Wiemers et al., 2004 ), PMP22 (ab15506, Abcam), CD9 (PharMingen), CD81 (PharMingen), CMTM5 (CKLF-like MARVEL-transmembrane domain-containing protein 5, also termed PETA-3; ab88964, Abcam; or M-13, Santa Cruz Biotechnology, yielding similar results), CD151 [455807, R&D Systems ( Cowin et al., 2006 )], septin 9 (SEPT9) [10769, Protein Tech Group and Nagata et al., (2004 ) (yielding similar results)], MAG (clone 513, Millipore Bioscience Research Reagents), 2′,3′-cyclic nucleotide phosphodiesterase (CNP; 11–5B, Sigma), COX4 (MS404, MitoSciences), and actin (Mab1501, Millipore Bioscience Research Reagents). . Immunoelectron microscopy. ..

other:

Article Title: BET degrader exhibits lower antiproliferative activity than its inhibitor via EGR1 recruiting septins to promote E2F1-3 transcription in triple-negative breast cancer.
Article Snippet: Antibodies against alpha-tubulin (66031–1–1 g), MCM2 (10513–1-AP), MCM5 (11703–1- AP), MCM7 (11225–1-AP), septin 2 (11397–1-AP), septin 7 (13818–1- AP) and septin 9 (10769–1-AP) were from Proteintech.

Article Title: Quantitative and Integrative Proteome Analysis of Peripheral Nerve Myelin Identifies Novel Myelin Proteins and Candidate Neuropathy Loci
Article Snippet: Raw image files were processed using Affymetrix GCOS 1.3 software to calculate individual probe cell intensity data and generate CEL Data Files.



Similar Products

92
Santa Cruz Biotechnology targeting proteins
Targeting Proteins, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/septin+9/Septin+9+Antibody/pmc12868481-56-24-20
Average 92 stars, based on 1 article reviews
targeting proteins - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

99
Thermo Fisher methylated septin 9 tumor dna
Methylated Septin 9 Tumor Dna, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/septin+9/DNA/fda_document____cdrh_docs_slash_pdf13_slash_p130001c-575-0-37
Average 99 stars, based on 1 article reviews
methylated septin 9 tumor dna - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

92
Proteintech septin 9
Septin 9, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/septin+9/SEPT9+Antibody/pm39503295-193-71-73
Average 92 stars, based on 1 article reviews
septin 9 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

90
Quest Diagnostics methylated septin 9 crc screening blood test
Methylated Septin 9 Crc Screening Blood Test, supplied by Quest Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/septin+9/methylated+septin+9+crc+screening+blood+test/pm38944206-63-19-27
Average 90 stars, based on 1 article reviews
methylated septin 9 crc screening blood test - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology antibodies targeting septin 9
Antibodies Targeting Septin 9, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/septin+9/Septin+9+Antibody/pm39018595-107-7-11
Average 92 stars, based on 1 article reviews
antibodies targeting septin 9 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

92
Bethyl sept7
Fig. 1. (A) Septin (SEPT) transcript expressions using RNA sequencing (SEPT7 immunostaining (red) in BEAS-2B cells infected with P. aeruginosa for 3 h [multiplicity of infection (MOI) =20] (green). Nuclei are labelled with DAPI (cyan). (D) Western blot of SEPT7 and reference protein glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in BEAS-2B cells after infecting with PAK (MOI = 5) for 3 h or not infected (NI) (representative of n= 3 experiments). " width="250" height="auto" />
Sept7, supplied by Bethyl, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/septin+9/Septin+9+Antibody/pm38636185-82-26-36
Average 92 stars, based on 1 article reviews
sept7 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

92
Fortis Life Sciences sept9
Fig. 2. SEPT7 mRNA expression analysis using qPCR (A) and SEPT7 (B, C), SEPT2 (B, D), SEPT6 (B, D), <t>SEPT9</t> (B, D), SEPT11 (B, D) protein expression using western blot in BEAS-2B after 72 h transfection of 5 nM control siRNA (siCTL, white circles) or SEPT7 siRNA (blue circles) (n=4, *p<0.05, Mann–Whitney test). (E) Amount of intracellular P. aeruginosa (Pa) (CFU/mL) in BEAS-2B cells transfected for 72 h with 5 nM of siCTL or SEPT7 siRNA and then infected for 30 min (orange circles, n=6), 1 h (purple circles, n=5) and 3 h (red circles, n=10) with Pa (MOI=5) [(*p<0.05, analysis of variance (ANOVA), Bonferroni correction)]. (F) IL-6 production by BEAS-2B cells transfected for 72 h with 5 nM of siCTL or SEPT7 siRNA in the non-infected (-, white circles) condition and after 3 h of Pa (red cir cles) infection (MOI=5) [(n= 9; *p<0.05, **p<0.01, ****p<0.0001 analysis of variance (ANOVA), Bonferroni correction)].
Sept9, supplied by Fortis Life Sciences, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/septin+9/Septin+9+Antibody/pm38636185-82-33-36
Average 92 stars, based on 1 article reviews
sept9 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

92
Novus Biologicals NBP2-13294
Fig. 2. SEPT7 mRNA expression analysis using qPCR (A) and SEPT7 (B, C), SEPT2 (B, D), SEPT6 (B, D), <t>SEPT9</t> (B, D), SEPT11 (B, D) protein expression using western blot in BEAS-2B after 72 h transfection of 5 nM control siRNA (siCTL, white circles) or SEPT7 siRNA (blue circles) (n=4, *p<0.05, Mann–Whitney test). (E) Amount of intracellular P. aeruginosa (Pa) (CFU/mL) in BEAS-2B cells transfected for 72 h with 5 nM of siCTL or SEPT7 siRNA and then infected for 30 min (orange circles, n=6), 1 h (purple circles, n=5) and 3 h (red circles, n=10) with Pa (MOI=5) [(*p<0.05, analysis of variance (ANOVA), Bonferroni correction)]. (F) IL-6 production by BEAS-2B cells transfected for 72 h with 5 nM of siCTL or SEPT7 siRNA in the non-infected (-, white circles) condition and after 3 h of Pa (red cir cles) infection (MOI=5) [(n= 9; *p<0.05, **p<0.01, ****p<0.0001 analysis of variance (ANOVA), Bonferroni correction)].
Nbp2 13294, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/septin+9/Septin-9+Antibody/pmc10809011-8-0-3
Average 92 stars, based on 1 article reviews
NBP2-13294 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

Image Search Results


Fig. 1. (A) Septin (SEPT) transcript expressions using RNA sequencing (

Journal: European journal of cell biology

Article Title: Septin-dependent defense mechanisms against Pseudomonas aeruginosa are stalled in cystic fibrosis bronchial epithelial cells.

doi: 10.1016/j.ejcb.2024.151416

Figure Lengend Snippet: Fig. 1. (A) Septin (SEPT) transcript expressions using RNA sequencing ("RNAseq") in the lungs (public data extracted from GTEXportal.org, TPM: transcripts per million). (B) SEPT mRNA expression in BEAS-2B cells (n=6) using quantitative polymerase chain reaction (qPCR) (reference: SEPT1, Cycle threshold means given between brackets). (C) SEPT7 immunostaining (red) in BEAS-2B cells infected with P. aeruginosa for 3 h [multiplicity of infection (MOI) =20] (green). Nuclei are labelled with DAPI (cyan). (D) Western blot of SEPT7 and reference protein glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in BEAS-2B cells after infecting with PAK (MOI = 5) for 3 h or not infected (NI) (representative of n= 3 experiments).

Article Snippet: The following SEPT antibodies have already been validated (Pfanzelter et al., 2018): SEPT2 (60075–1, 1/20 000 Proteintech, Manchester, UK), SEPT6 (HPA005665, 1/1000, Atlas Antibody, Bromma, Sweden), SEPT7 (18991; 1/1000, IBL, Minneapolis, MN, USA), SEPT9 (A302–353A-M, 1/1000 Bethyl Laboratories, Montgomery, Texas), and SEPT11 (A304–1761-M, 1/1000, Bethyl laboratories).

Techniques: RNA Sequencing, Expressing, Real-time Polymerase Chain Reaction, Immunostaining, Infection, Western Blot

Fig. 2. SEPT7 mRNA expression analysis using qPCR (A) and SEPT7 (B, C), SEPT2 (B, D), SEPT6 (B, D), SEPT9 (B, D), SEPT11 (B, D) protein expression using western blot in BEAS-2B after 72 h transfection of 5 nM control siRNA (siCTL, white circles) or SEPT7 siRNA (blue circles) (n=4, *p<0.05, Mann–Whitney test). (E) Amount of intracellular P. aeruginosa (Pa) (CFU/mL) in BEAS-2B cells transfected for 72 h with 5 nM of siCTL or SEPT7 siRNA and then infected for 30 min (orange circles, n=6), 1 h (purple circles, n=5) and 3 h (red circles, n=10) with Pa (MOI=5) [(*p<0.05, analysis of variance (ANOVA), Bonferroni correction)]. (F) IL-6 production by BEAS-2B cells transfected for 72 h with 5 nM of siCTL or SEPT7 siRNA in the non-infected (-, white circles) condition and after 3 h of Pa (red cir cles) infection (MOI=5) [(n= 9; *p<0.05, **p<0.01, ****p<0.0001 analysis of variance (ANOVA), Bonferroni correction)].

Journal: European journal of cell biology

Article Title: Septin-dependent defense mechanisms against Pseudomonas aeruginosa are stalled in cystic fibrosis bronchial epithelial cells.

doi: 10.1016/j.ejcb.2024.151416

Figure Lengend Snippet: Fig. 2. SEPT7 mRNA expression analysis using qPCR (A) and SEPT7 (B, C), SEPT2 (B, D), SEPT6 (B, D), SEPT9 (B, D), SEPT11 (B, D) protein expression using western blot in BEAS-2B after 72 h transfection of 5 nM control siRNA (siCTL, white circles) or SEPT7 siRNA (blue circles) (n=4, *p<0.05, Mann–Whitney test). (E) Amount of intracellular P. aeruginosa (Pa) (CFU/mL) in BEAS-2B cells transfected for 72 h with 5 nM of siCTL or SEPT7 siRNA and then infected for 30 min (orange circles, n=6), 1 h (purple circles, n=5) and 3 h (red circles, n=10) with Pa (MOI=5) [(*p<0.05, analysis of variance (ANOVA), Bonferroni correction)]. (F) IL-6 production by BEAS-2B cells transfected for 72 h with 5 nM of siCTL or SEPT7 siRNA in the non-infected (-, white circles) condition and after 3 h of Pa (red cir cles) infection (MOI=5) [(n= 9; *p<0.05, **p<0.01, ****p<0.0001 analysis of variance (ANOVA), Bonferroni correction)].

Article Snippet: The following SEPT antibodies have already been validated (Pfanzelter et al., 2018): SEPT2 (60075–1, 1/20 000 Proteintech, Manchester, UK), SEPT6 (HPA005665, 1/1000, Atlas Antibody, Bromma, Sweden), SEPT7 (18991; 1/1000, IBL, Minneapolis, MN, USA), SEPT9 (A302–353A-M, 1/1000 Bethyl Laboratories, Montgomery, Texas), and SEPT11 (A304–1761-M, 1/1000, Bethyl laboratories).

Techniques: Expressing, Western Blot, Transfection, Control, MANN-WHITNEY, Infection

Fig. 4. (A) Kinetics of SEPT mRNA expression measured by RNAseq in primary bronchial epithelial cells from patients without CF (Non-CF, N = 4) or with CF (N = 4) and infected with P. aeruginosa (PAK strain, MOI 0.25) for 0, 2, 4, or 6 h (*p<0.05: CF vs. non-CF; #p<0.05: CF 4 h vs. CF 2 h, Benjamini and Hochberg corrected p- value) [data were extracted from (Balloy et al., 2015)]. (B) Western blot and quantification of SEPT7 and reference protein GAPDH expression in primary bronchial epithelial cells from non-CF donors (non-CF1, non-CF2) and CF patients (CF1, CF2) at baseline and (C) from non-CF3 and CF2 after 3 h of Pa infection (red circled) (MOI = 10) or non-infected (-; white circle) (n=4; ns: non-significant Mann–Whitney test). (D) Immunostaining of SEPT7 (red) in primary bronchial epithelial cells from non-CF1 and CF1 infected for 3 h with Pa (MOI=20) (green). Nuclei are labelled with DAPI (cyan). (E) Western blot of SEPT7 and reference protein GAPDH in Non-CF2 and CF2 cells after 96 h transfection with 10 nM siCTL or SEPT7 siRNA. Amount of intracellular Pa (CFU/mL) in primary non-CF2 and CF2 cells (n=6) transfected for 72 h with 10 nM CTL (white circle) or SEPT7 (red circles) siRNA and then infected for 4 h with Pa (MOI=10) (n=4; ***p<0.001, ANOVA, Bonferroni correction). (F) Interleukin-6 (IL-6) production by non-CF2 and CF2 cells transfected for 72 h with 10 nM CTL (white circle) or SEPT7 (red circle) siRNA in non-infected and after 4 h of Pa infection (MOI=10) (n= 4; **p<0.01, ***p<0.001, ****p<0.0001, ANOVA, Bonferroni correction).

Journal: European journal of cell biology

Article Title: Septin-dependent defense mechanisms against Pseudomonas aeruginosa are stalled in cystic fibrosis bronchial epithelial cells.

doi: 10.1016/j.ejcb.2024.151416

Figure Lengend Snippet: Fig. 4. (A) Kinetics of SEPT mRNA expression measured by RNAseq in primary bronchial epithelial cells from patients without CF (Non-CF, N = 4) or with CF (N = 4) and infected with P. aeruginosa (PAK strain, MOI 0.25) for 0, 2, 4, or 6 h (*p<0.05: CF vs. non-CF; #p<0.05: CF 4 h vs. CF 2 h, Benjamini and Hochberg corrected p- value) [data were extracted from (Balloy et al., 2015)]. (B) Western blot and quantification of SEPT7 and reference protein GAPDH expression in primary bronchial epithelial cells from non-CF donors (non-CF1, non-CF2) and CF patients (CF1, CF2) at baseline and (C) from non-CF3 and CF2 after 3 h of Pa infection (red circled) (MOI = 10) or non-infected (-; white circle) (n=4; ns: non-significant Mann–Whitney test). (D) Immunostaining of SEPT7 (red) in primary bronchial epithelial cells from non-CF1 and CF1 infected for 3 h with Pa (MOI=20) (green). Nuclei are labelled with DAPI (cyan). (E) Western blot of SEPT7 and reference protein GAPDH in Non-CF2 and CF2 cells after 96 h transfection with 10 nM siCTL or SEPT7 siRNA. Amount of intracellular Pa (CFU/mL) in primary non-CF2 and CF2 cells (n=6) transfected for 72 h with 10 nM CTL (white circle) or SEPT7 (red circles) siRNA and then infected for 4 h with Pa (MOI=10) (n=4; ***p<0.001, ANOVA, Bonferroni correction). (F) Interleukin-6 (IL-6) production by non-CF2 and CF2 cells transfected for 72 h with 10 nM CTL (white circle) or SEPT7 (red circle) siRNA in non-infected and after 4 h of Pa infection (MOI=10) (n= 4; **p<0.01, ***p<0.001, ****p<0.0001, ANOVA, Bonferroni correction).

Article Snippet: The following SEPT antibodies have already been validated (Pfanzelter et al., 2018): SEPT2 (60075–1, 1/20 000 Proteintech, Manchester, UK), SEPT6 (HPA005665, 1/1000, Atlas Antibody, Bromma, Sweden), SEPT7 (18991; 1/1000, IBL, Minneapolis, MN, USA), SEPT9 (A302–353A-M, 1/1000 Bethyl Laboratories, Montgomery, Texas), and SEPT11 (A304–1761-M, 1/1000, Bethyl laboratories).

Techniques: Expressing, Infection, Western Blot, MANN-WHITNEY, Immunostaining, Transfection

Fig. 2. SEPT7 mRNA expression analysis using qPCR (A) and SEPT7 (B, C), SEPT2 (B, D), SEPT6 (B, D), SEPT9 (B, D), SEPT11 (B, D) protein expression using western blot in BEAS-2B after 72 h transfection of 5 nM control siRNA (siCTL, white circles) or SEPT7 siRNA (blue circles) (n=4, *p<0.05, Mann–Whitney test). (E) Amount of intracellular P. aeruginosa (Pa) (CFU/mL) in BEAS-2B cells transfected for 72 h with 5 nM of siCTL or SEPT7 siRNA and then infected for 30 min (orange circles, n=6), 1 h (purple circles, n=5) and 3 h (red circles, n=10) with Pa (MOI=5) [(*p<0.05, analysis of variance (ANOVA), Bonferroni correction)]. (F) IL-6 production by BEAS-2B cells transfected for 72 h with 5 nM of siCTL or SEPT7 siRNA in the non-infected (-, white circles) condition and after 3 h of Pa (red cir cles) infection (MOI=5) [(n= 9; *p<0.05, **p<0.01, ****p<0.0001 analysis of variance (ANOVA), Bonferroni correction)].

Journal: European journal of cell biology

Article Title: Septin-dependent defense mechanisms against Pseudomonas aeruginosa are stalled in cystic fibrosis bronchial epithelial cells.

doi: 10.1016/j.ejcb.2024.151416

Figure Lengend Snippet: Fig. 2. SEPT7 mRNA expression analysis using qPCR (A) and SEPT7 (B, C), SEPT2 (B, D), SEPT6 (B, D), SEPT9 (B, D), SEPT11 (B, D) protein expression using western blot in BEAS-2B after 72 h transfection of 5 nM control siRNA (siCTL, white circles) or SEPT7 siRNA (blue circles) (n=4, *p<0.05, Mann–Whitney test). (E) Amount of intracellular P. aeruginosa (Pa) (CFU/mL) in BEAS-2B cells transfected for 72 h with 5 nM of siCTL or SEPT7 siRNA and then infected for 30 min (orange circles, n=6), 1 h (purple circles, n=5) and 3 h (red circles, n=10) with Pa (MOI=5) [(*p<0.05, analysis of variance (ANOVA), Bonferroni correction)]. (F) IL-6 production by BEAS-2B cells transfected for 72 h with 5 nM of siCTL or SEPT7 siRNA in the non-infected (-, white circles) condition and after 3 h of Pa (red cir cles) infection (MOI=5) [(n= 9; *p<0.05, **p<0.01, ****p<0.0001 analysis of variance (ANOVA), Bonferroni correction)].

Article Snippet: The following SEPT antibodies have already been validated (Pfanzelter et al., 2018): SEPT2 (60075–1, 1/20 000 Proteintech, Manchester, UK), SEPT6 (HPA005665, 1/1000, Atlas Antibody, Bromma, Sweden), SEPT7 (18991; 1/1000, IBL, Minneapolis, MN, USA), SEPT9 (A302–353A-M, 1/1000 Bethyl Laboratories, Montgomery, Texas), and SEPT11 (A304–1761-M, 1/1000, Bethyl laboratories).

Techniques: Expressing, Western Blot, Transfection, Control, MANN-WHITNEY, Infection